2016Journal of Pharmacological and Toxicological MethodsRequires access

New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts

Péter Kui, Szabolcs Orosz, Hedvig Takács, Annamária Sarusi, Norbert Csík, Ferenc Rárosi, Csongor Csekõ, András Varró, Julius Gy. Papp, Tamás Forster, Attila S. Farkas, András Farkas, András Farkas, András Farkas

Open publisher page 9 citations

Abstract

This record does not include an abstract. Use the full-text link above if available.

About this research paper

What this paper is about

An abstract is not available in the OpenAlex record for this paper.

Why it matters

OpenAlex reports 9 citations for this work. Citation counts describe recorded attention and do not establish research quality.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Key concepts: Proarrhythmia, QT interval, Dofetilide, Cisapride, Torsades de pointes, Pharmacology, hERG, Sotalol

Related papers

Back to paper searchBrowse research topicsOriginal source
New in vitro model for proarrhythmia safety screening: IKs inhibition potentiates the QTc prolonging effect of IKr inhibitors in isolated guinea pig hearts — Research Paper | ScholarLens